Mutation underlying resistance of Plasmodium berghei to atovaquone in the quinone binding domain 2 (Qo2) of the cytochrome b gene

Parasitology International

Volumn 57, Issue 2, 2008, Pages 229-232

  Siregar, Josephine E ^a,d   Syafruddin, Din ^a,b   Matsuoka, Hiroyuki ^c   Kita, Kiyoshi ^d   Marzuki, Sangkot ^a  

^a EIJKMAN INSTITUTE FOR MOLECULAR BIOLOGY   (Indonesia)

^b HASANUDDIN UNIVERSITY   (Indonesia)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Atovaquone resistance; Cytochrome b gene mutations; Plasmodium berghei

Indexed keywords

ATOVAQUONE; CYTOCHROME B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE MUTATION; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTOZOAL GENETICS; PROTOZOAL INFECTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIMALARIALS; ATOVAQUONE; BENZOQUINONES; CYTOCHROME B GROUP; DRUG RESISTANCE; MALARIA; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUTATION; PARASITEMIA; PARASITIC SENSITIVITY TESTS; PLASMODIUM BERGHEI;

PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

EID: 40849120539     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2007.12.002     Document Type: Article

References (14)

1. Fry M., and Pudney M. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone(566C80). Biochem Pharmacol 43 (1992) 1545-1553
2. Vaidya A.B., Lashgari M.S., Pologe L.G., and Morrisey J. Structural features of Plasmodium cytochrome b that may underline susceptibility to 8-aminoquinolines and hydroxynaphthoquinones. Mol Biochem Parasitol 58 (1993) 33-42
3. Srivastava I.K., Rottenberg H., and Vaidya A.B. Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. J Biol Chem 272 (1997) 3961-3966
4. Syafruddin D., Siregar J.E., and Marzuki S. Mutations in the cytochrome b gene of Plasmodium berghei conferring resistance to atovaquone. Mol Biochem Parasitol 104 (1999) 185-194
5. Srivastava I.K., Morrisey J.M., Darrouzet E., Daldal F., and Vaidya A.B. Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. Mol Microbiol 33 (1999) 704-711
6. Korsinczky M., Chen N., Kotecka B., Saul A., Rieckmann K., and Cheng Q. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrob Agents Chemother 44 (2000) 2100-2108
7. Walker D.J., Wakefield A.E., Dohn M.N., Miller R.F., Baughman R.P., Hossler P.A., et al. Sequence polymorphism in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure. J Infect Dis 178 (1998) 1767-1775
8. o domain mutations as a mechanism of atovaquone-resistance. Mol Biochem Parasitol 108 (2000) 1-12
9. Fivelman Q.L., Butcher G.A., Adagu I.S., Warhust D.C., and Pasvol G. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. Malaria J I (2002) 1-4
10. David K.P., Alifrangis M., Salanti A., Vestergaard L.S., Ronn A., and Bygbjerg I.B. Atovaquone/proguanil resistance in Africa: a case report. Scand J Infect Dis 35 (2003) 897-898
11. Musset L., Bouchaud O., Matheon S., Massias L., and Le B.J. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations. Microbes Infect 11 (2006) 2599-2604
12. Schwöbel B., Alifrangis M., Salanti A., and Jelinek T. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker. Malaria J 2 (2003) 1-7
13. 1 complex. J Biol Chem 278 (2003) 31312-31318
14. 1 complex and confer anti-malarial drug resistance in Saccharomyces cerevisiae. J Biol Chem 280 (2005) 17142-17148